Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.

[1]  M. Huentelman,et al.  Prevention of Cardiac Hypertrophy by Angiotensin II Type-2 Receptor Gene Transfer , 2004, Hypertension.

[2]  F. Luft,et al.  Cardiac hypertrophy and fibrosis in chronic l-NAME-treated AT2 receptor-deficient mice , 2004, Journal of hypertension.

[3]  R. Widdop,et al.  Angiotensin AT2 receptors: cardiovascular hope or hype? , 2003, British journal of pharmacology.

[4]  Edward G Lakatta,et al.  Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging , 2003, Circulation.

[5]  H. Matsubara,et al.  Cardiac Angiotensin II Type 2 Receptor Activates the Kinin/NO System and Inhibits Fibrosis , 2003, Hypertension.

[6]  B. Lévy,et al.  AT2 Receptor-Mediated Relaxation Is Preserved After Long-Term AT1 Receptor Blockade , 2002, Hypertension.

[7]  A. Kapke,et al.  Role of AT2 Receptors in the Cardioprotective Effect of AT1 Antagonists in Mice , 2002, Hypertension.

[8]  R. Chen,et al.  Effect of Angiotensin II Type 1 Receptor Blockade on Cardiac Remodeling in Angiotensin II Type 2 Receptor Null Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[9]  E. Frohlich,et al.  Isolated Systolic Hypertension in Elderly WKY Is Reversed With l-Arginine and ACE Inhibition , 2001, Hypertension.

[10]  J. Paull,et al.  Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats , 2001, Journal of hypertension.

[11]  T. Ichiki,et al.  Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension , 2001, Circulation.

[12]  E. Frohlich,et al.  Coronary Hemodynamic and Ventricular Responses to Angiotensin Type 1 Receptor Inhibition in SHR: Interaction With Angiotensin Type 2 Receptors , 2001, Hypertension.

[13]  M. Safar,et al.  Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. , 2001, Journal of the American College of Cardiology.

[14]  H. Sasamura,et al.  Angiotensin II Type 2 Receptors Stimulate Collagen Synthesis in Cultured Vascular Smooth Muscle Cells , 2000, Hypertension.

[15]  T. Oyama,et al.  Activity and responsiveness of the renin-angiotensin system in the aging rat. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[16]  Y. Ouchi,et al.  Inhibitory Effect of Angiotensin II Type 2 Receptor on Coronary Arterial Remodeling After Aortic Banding in Mice , 2000, Circulation.

[17]  A. Danser,et al.  AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction. , 2001, American journal of physiology. Heart and circulatory physiology.

[18]  K. Catt,et al.  International union of pharmacology. XXIII. The angiotensin II receptors. , 2000, Pharmacological reviews.

[19]  R. Bohle,et al.  Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study. , 2000, The American journal of pathology.

[20]  R. Carey,et al.  Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. , 2000, Hypertension.

[21]  R. Touyz,et al.  Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. , 2000, Hypertension.

[22]  B. Gigante,et al.  Role of the angiotensin II AT2‐subtype receptors in the blood pressure‐lowering effect of losartan in salt‐restricted rats , 1998, Journal of hypertension.

[23]  Y. Mori,et al.  Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. , 1998, Circulation research.

[24]  J Liu,et al.  Large artery remodeling during aging: biaxial passive and active stiffness. , 1998, Hypertension.

[25]  B. Lévy,et al.  Cardiac Senescence Is Associated with Enhanced Expression of Angiotensin II Receptor Subtypes. , 1998, Endocrinology.

[26]  E. Núñez,et al.  Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar‐Kyoto rats , 1998, Journal of hypertension.

[27]  Y. Mori,et al.  Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. , 1997, Circulation.

[28]  Y. Fujisawa,et al.  Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. , 1997, Clinical and experimental hypertension.

[29]  M. Sugano,et al.  Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. , 1997, Hypertension.

[30]  O. Carretero,et al.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. , 1997, The Journal of clinical investigation.

[31]  M. Safar,et al.  Aortic collagen, aortic stiffness, and AT1 receptors in experimental and human hypertension. , 1996, Canadian journal of physiology and pharmacology.

[32]  I. Dixon,et al.  Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. , 1996, Journal of molecular and cellular cardiology.

[33]  C. Delcayre,et al.  Molecular and cellular biology of the senescent hypertrophied and failing heart. , 1995, The American journal of cardiology.

[34]  D. Campbell,et al.  Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin‐Converting Enzyme , 1995, Journal of cardiovascular pharmacology.

[35]  R. Widdop,et al.  Effect of acute and chronic treatment with the angiotensin II subtype 1 receptor antagonist EXP 3174 on baroreflex function in conscious spontaneously hypertensive rats. , 1995, Journal of Hypertension.

[36]  B. Swynghedauw,et al.  Activation of Angiotensinogen and Angiotensin‐Converting Enzyme Gene Expression in the Left Ventricle of Senescent Rats , 1994, Circulation.

[37]  H. Schunkert,et al.  Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. , 1994, The American journal of physiology.

[38]  K. Weber,et al.  Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. , 1994, Journal of molecular and cellular cardiology.

[39]  J. Michel,et al.  Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. , 1994, The American journal of physiology.

[40]  G Olivetti,et al.  Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. , 1990, Circulation research.

[41]  C. Johnston,et al.  Hormonal Responses to Angiotensin Blockade: Comparison between Receptor Antagonism and Converting Enzyme Inhibition , 1980, Circulation research.

[42]  J. Díez,et al.  Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. , 1999, Journal of hypertension.